Home News Fidson Healthcare Partners with Chinese Firms to Boost HIV Drug Access in Africa
News

Fidson Healthcare Partners with Chinese Firms to Boost HIV Drug Access in Africa

Share
Fidson Healthcare Partners with Chinese Firms to Boost HIV Drug Access in Africa | Daily Report Nigeria
Share

Fidson Healthcare Plc has formalised a Strategic Cooperation Memorandum with three Chinese entities: Jiangsu Aidea Pharma, Nanjing PharmaBlock, and the China-Africa Development Fund.

Daily Report Nigeria reports that the agreement, signed in Beijing, aims to enhance the availability of HIV medications across Africa.

Also, the collaboration will see these four organisations combine their expertise to establish a new joint venture pharmaceutical plant in Nigeria.

The signing ceremony was attended by a Nigerian delegation led by Dr Fidelis Ayebae, the founder and Managing Director of Fidson Healthcare Plc, along with Dr Babatunde Ipaye and Mr Oshoke Ayebae.

ATTENTION: Click HERE to join our WhatsApp group and receive News updates directly on your WhatsApp!

Ayebae explained that this partnership is set to massively improve access to HIV treatment for Nigerians and other Africans.

He said:

This collaboration will leverage the strengths of all parties to create a new pharmaceutical plant in Nigeria, promoting self-reliance in healthcare delivery, particularly in combating HIV.”

READ ALSO: 1.6 Million Nigerians with HIV Are on Treatment – NACA

The agreement includes sharing information and resources, exploring investment opportunities in West African pharmaceutical markets, and implementing cooperative investment projects.

Notably, the signing followed a series of engagements, including a visit by Dr Heliang Fu, Chairman of Jiangsu Aidea Pharma, to Nigeria earlier this year. During his visit, Dr Fu toured the Lekki Free Trade Zone, the proposed site for the state-of-the-art manufacturing facility.

Fu remarked that the partnership exemplifies international cooperation to address critical medical challenges.

The new facility is expected to become a hub for pharmaceutical excellence, leveraging the strategic location and infrastructure of the Lekki Free Trade Zone to drive economic growth and improve healthcare.

Dr Ayebae stressed that this initiative would address the medical needs of over 1.9 million people living with HIV in Nigeria, believing that the combined strengths of all parties will revitalise the healthcare sector in Africa.

Fidson Healthcare Plc, listed on the Lagos Stock Exchange, has seen its stock value decrease by 24.6% this year, currently valued at N30.3 billion.

 

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Tinubu Pledges Support for Fair Labour Practices, Workers' Welfare | Daily Report Nigeria
News

Tinubu Pledges Support for Fair Labour Practices, Workers’ Welfare

President Bola Ahmed Tinubu reaffirms commitment to fair labour practices and protecting...

JAMB Delists Five Exam Centres, Arrests 27 Impersonators in 2025 UTME | Daily Report Nigeria
News

JAMB Delists Five Exam Centres, Arrests 27 Impersonators in 2025 UTME

JAMB delists five CBT centres for failing to meet technical standards. Over...

Appeal Court Did Not Acquit Nnamdi Kanu – FG
News

Insecurity in Southeast: Nnamdi Kanu Seeks EU, US Probe Ahead of Trial

Nnamdi Kanu urges EU, US to probe state-sponsored insecurity in Southeast Nigeria....

Reactions As Wizkid's Son Snubs Peller's Link Up Request | Daily Report Nigeria
News

Reactions As Wizkid’s Son Snubs Peller’s Link Up Request

Controversial Nigerian streamer, Peller has reacted after being snubbed by music superstar,...